Sells breast imaging scanners that use low-energy sound to hospitals, radiology centers and other healthcare providers.
10-K for FY2025, filed Mar 25, 2026The Company is a medical device company founded in 2012 and engaged in the research, development, and commercialization of innovative body…View ↗
The Company’s technology provides automated 3D imaging of the breast without ionizing radiation and without breast compression, enabling…View ↗
Building on its clinical and technology strategy, the Company intends to drive continued growth through a focused commercial expansion…View ↗
Most revenue comes from selling QT Breast Scanners; sales are counted when the equipment is transferred to the customer. Training and maintenance are invoiced based on work completed.
10-K for FY2025, filed Mar 25, 2026
FY2025 revenue by product or service ↗$18.9M
10-K for FY2025, filed Mar 25, 2026
$18.9M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2025, filed Mar 25, 2026 |
99% |
Product, FY2025
$18.8M Sources
|
Sold outright |
|
Service
|
0.9% |
Service, FY2025
$175K Sources
|
Hospitals and radiology centers are target buyers; U.S. sales run through NXC, with some direct sales, while international sales use distribution partners.
10-K for FY2025, filed Mar 25, 2026Building on its clinical and technology strategy, the Company intends to drive continued growth through a focused commercial expansion…View ↗
Subsequently, effective June 10, 2024, the Company and NXC replaced the NXC Sales Agent Agreement with the “NXC Distribution Agreement”.…View ↗
In parallel with its U.S. growth strategy, the Company intends to expand into international markets, beginning with the Gulf Cooperation…View ↗
No. It lost $21.1M in FY2025.
10-K for FY2025, filed Mar 25, 2026
−$4.4MView ↗
10-K for FY2025, filed Mar 25, 2026
−$21.1MView ↗
10-K for FY2025, filed Mar 25, 2026
−$9.1MView ↗
10-Q for Q2 FY2026, filed Aug 12, 2026
−$11.1MView ↗
10-Q for Q2 FY2026, filed Aug 12, 2026
Open tableView ↗
8-K, filed Aug 12, 2026
Reaffirms full-year 2026 revenue guidance of approximately $39 millionView ↗
From merger-seeking company to imaging business
The older report describes a company formed to complete a merger with QT Imaging; the latest report describes a medical-device business developing and commercializing low-energy breast imaging systems.
10-K for FY2022, filed Mar 31, 2023 10-K for FY2025, filed Mar 25, 2026We are a Delaware corporation formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase…View ↗
The Company is a medical device company founded in 2012 and engaged in the research, development, and commercialization of innovative body…View ↗
Loading...